COVID-19

Information on COVID-19

Media & Press Releases
27 July 2021
ISPE has been honored as the winner of a 2021 APEX Award for Publication Excellence in the COVID-19 Media Government/Association content category for the four-article Special Report on COVID-19 impact published in the July-August 2020 issue. The APEX...
iSpeak Blog

Early in March 2020, many around the world viewed the sight of collapsing intensive care units in Northern Italy, overwhelmed by COVID19, with great anxiety and we wondered how we might address the inevitable arrival of the virus at our doorsteps. This concern led to a home-grown initiative in Ireland that brought together representatives of health, commercial and academic organisations...

Off
Listen to a panel of global experts from the Sterile Products Processing committee as they discuss the challenges they have encountered during the global COVID-19 pandemic. They’re here to share stories and lessons...
iSpeak Blog

The current COVID-19 pandemic has heightened the awareness and attention to virus safety and risk mitigation for manufacturers. Each manufacturer has a strategy in place to mitigate the risk, however by manufacturers working together, this can lead to synergies and best practices in the way that the risk is managed. Also, additional guidance is required by the Industry in a field that is...

iSpeak Blog

FDA Commissioner Stephen M. Hahn, MD, spoke about the lessons learned from COVID-19 in a presentation during the ISPE Annual Member Meeting on 5 November at the 2020 ISPE Annual Meeting & Expo. He discussed how the FDA has been responding to the pandemic, including how actions taken in response to the pandemic have been combined with FDA knowledge from prior public health crises to...

Off
Learning Level: Basic - Drug shortages are not just a supply chain problem. They are a problem for patients. Sometimes these patients are so at risk, resolving the shortage could make the ultimate difference. During this...
Special Reports

Vaccine development is an intricate undertaking, which may involve numerous challenges from the initial process of identifying an antigen to the final steps of delivering and administering the licensed product. The COVID-19 pandemic has put a spotlight on the science of vaccine development. As the world awaits a vaccine for the coronavirus, manufacturers face unprecedented pressure to respond...

Off
Learning Level: Basic - In a fireside chat format our speakers will discuss their vision of the Pharmaceutical Supply Chain in the next 3 to 5 years as the Pandemic and other factors accelerate change. Understanding the...